Cargando…
Nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expression
The Nrf2 signaling pathway prevents cancer initiation, but genetic mutations that activate this pathway are found in various types of cancer. The molecular mechanisms underlying this Janus-headed character are still not understood. Here, we show that sustained Nrf2 activation induces proliferation a...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618468/ https://www.ncbi.nlm.nih.gov/pubmed/36209041 http://dx.doi.org/10.1016/j.redox.2022.102453 |
_version_ | 1784821056507215872 |
---|---|
author | Fragoulis, Athanassios Schenkel, Julia Schröder, Nicole Brandt, Elisa Fabiana Weiand, Mathias Neu, Tabita Ramadori, Pierluigi Caspers, Tim Kant, Sebastian Pufe, Thomas Mohs, Antje Trautwein, Christian Longerich, Thomas Streetz, Konrad Ludwig Wruck, Christoph Jan |
author_facet | Fragoulis, Athanassios Schenkel, Julia Schröder, Nicole Brandt, Elisa Fabiana Weiand, Mathias Neu, Tabita Ramadori, Pierluigi Caspers, Tim Kant, Sebastian Pufe, Thomas Mohs, Antje Trautwein, Christian Longerich, Thomas Streetz, Konrad Ludwig Wruck, Christoph Jan |
author_sort | Fragoulis, Athanassios |
collection | PubMed |
description | The Nrf2 signaling pathway prevents cancer initiation, but genetic mutations that activate this pathway are found in various types of cancer. The molecular mechanisms underlying this Janus-headed character are still not understood. Here, we show that sustained Nrf2 activation induces proliferation and dedifferentiation of a Wnt-responsive perivenular hepatic progenitor cell population, transforming them into metastatic cancer cells. The neoplastic lesions display many histological features known from human hepatoblastoma. We describe an Nrf2-induced upregulation of β-catenin expression and its activation as the underlying mechanism for the observed malignant transformation. Thus, we have identified the Nrf2–β-catenin axis promoting proliferation of hepatic stem cells and triggering tumorigenesis. These findings support the concept that different functional levels of Nrf2 control both the protection against various toxins as well as liver regeneration by activating hepatic stem cells. Activation of the hepatic stem cell compartment confers the observation that unbridled Nrf2 activation may trigger tumorigenesis. |
format | Online Article Text |
id | pubmed-9618468 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-96184682022-11-01 Nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expression Fragoulis, Athanassios Schenkel, Julia Schröder, Nicole Brandt, Elisa Fabiana Weiand, Mathias Neu, Tabita Ramadori, Pierluigi Caspers, Tim Kant, Sebastian Pufe, Thomas Mohs, Antje Trautwein, Christian Longerich, Thomas Streetz, Konrad Ludwig Wruck, Christoph Jan Redox Biol Articles from the Special Issue on Redox Modulation of Cancer Heterogeneity, Therapeutic Resistance and Immunotherapy Efficacy; Edited by Dr. Anita Hjelmeland The Nrf2 signaling pathway prevents cancer initiation, but genetic mutations that activate this pathway are found in various types of cancer. The molecular mechanisms underlying this Janus-headed character are still not understood. Here, we show that sustained Nrf2 activation induces proliferation and dedifferentiation of a Wnt-responsive perivenular hepatic progenitor cell population, transforming them into metastatic cancer cells. The neoplastic lesions display many histological features known from human hepatoblastoma. We describe an Nrf2-induced upregulation of β-catenin expression and its activation as the underlying mechanism for the observed malignant transformation. Thus, we have identified the Nrf2–β-catenin axis promoting proliferation of hepatic stem cells and triggering tumorigenesis. These findings support the concept that different functional levels of Nrf2 control both the protection against various toxins as well as liver regeneration by activating hepatic stem cells. Activation of the hepatic stem cell compartment confers the observation that unbridled Nrf2 activation may trigger tumorigenesis. Elsevier 2022-09-13 /pmc/articles/PMC9618468/ /pubmed/36209041 http://dx.doi.org/10.1016/j.redox.2022.102453 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Articles from the Special Issue on Redox Modulation of Cancer Heterogeneity, Therapeutic Resistance and Immunotherapy Efficacy; Edited by Dr. Anita Hjelmeland Fragoulis, Athanassios Schenkel, Julia Schröder, Nicole Brandt, Elisa Fabiana Weiand, Mathias Neu, Tabita Ramadori, Pierluigi Caspers, Tim Kant, Sebastian Pufe, Thomas Mohs, Antje Trautwein, Christian Longerich, Thomas Streetz, Konrad Ludwig Wruck, Christoph Jan Nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expression |
title | Nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expression |
title_full | Nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expression |
title_fullStr | Nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expression |
title_full_unstemmed | Nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expression |
title_short | Nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expression |
title_sort | nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expression |
topic | Articles from the Special Issue on Redox Modulation of Cancer Heterogeneity, Therapeutic Resistance and Immunotherapy Efficacy; Edited by Dr. Anita Hjelmeland |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618468/ https://www.ncbi.nlm.nih.gov/pubmed/36209041 http://dx.doi.org/10.1016/j.redox.2022.102453 |
work_keys_str_mv | AT fragoulisathanassios nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression AT schenkeljulia nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression AT schrodernicole nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression AT brandtelisafabiana nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression AT weiandmathias nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression AT neutabita nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression AT ramadoripierluigi nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression AT casperstim nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression AT kantsebastian nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression AT pufethomas nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression AT mohsantje nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression AT trautweinchristian nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression AT longerichthomas nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression AT streetzkonradludwig nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression AT wruckchristophjan nrf2inducesmalignanttransformationofhepaticprogenitorcellsbyinducingbcateninexpression |